Although previous studies have demonstrated that RNA-binding proteins (RBPs) were frequently mutated in AML patients and essential for leukemia growth [30, 31], how RBPs genes regulate HOXA9 expression and AML survival remains uncharacterized. This evidence concerns the gene HOXA9 and acute myeloid leukemia.